Full coverage
The White House withdrew Heidi Overton’s nomination to lead the FDA.
The withdrawal came as Overton faced opposition and doubts from Republican senators, ahead of a Senate health committee vote scheduled for Wednesday. The FDA is currently led by acting Commissioner Kyle Diamantas.
What the reports agree on
- The White House withdrew Overton’s nomination to lead the FDA. Axios, The Hill, ABC News, CBS News
- The Senate health committee had scheduled a vote on Overton’s nomination for Wednesday. CBS News, Axios, The Hill
- Some Republican senators had doubts or concerns about Overton’s nomination. CBS News, Axios, The Hill, ABC News
- Acting Commissioner Kyle Diamantas leads the FDA. CBS News, Axios
Reported by one outlet
- The White House had discussed possible replacement candidates, including people who could serve as acting commissioner without Senate confirmation. CBS News
- Sen. Bill Cassidy said he had strong concerns about Overton’s role in changes to childhood vaccine recommendations. Axios
- Republicans held a one-vote majority on the Senate health committee. The Hill
- Overton testified before the Senate Health, Education, Labor, and Pensions Committee on September 24, 2026. ABC News
The original reports
- CBS News White House drops Heidi Overton's nomination for FDA commissioner
- The Hill White House pulls nomination of Heidi Overton to lead FDA
- ABC News Trump's pick Heidi Overton dropped as nominee for FDA commissioner
- Axios Scoop: White House drops Heidi Overton's FDA nomination
- CBS News Trump FDA nominee Heidi Overton struggling to win GOP support